Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L) - Wikidata - awgldk - TriplyDB

Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)

Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)

http://www.wikidata.org/entity/Q31107094

about

Healthcare quality in systemic lupus erythematosus: using Donabedian’s conceptual framework to understand what we know Current and emerging treatment options in the management of lupus Hydroxychloroquine-related retinal toxicity Identification of activators of ERK5 transcriptional activity by high-throughput screening and the role of endothelial ERK5 in vasoprotective effects induced by statins and antimalarial agents Emerging therapies for systemic lupus erythematosus--focus on targeting interferon-alpha Violacein Treatment Modulates Acute and Chronic Inflammation through the Suppression of Cytokine Production and Induction of Regulatory T Cells Primary cardiac disease in systemic lupus erythematosus patients: protective and risk factors--data from a multi-ethnic Latin American cohort.Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV).Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort.Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United States Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort Cardiovascular involvement in autoimmune diseases.Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus.Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus Systemic lupus erythematosus: review of synthetic drugs.Update on systemic lupus erythematosus pregnancy Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus Prognosis for Hospitalized Patients with Systemic Lupus Erythematosus in China: 5-Year Update of the Jiangsu Cohort.Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence.Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study.Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block.Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review.Predictors of major infections in systemic lupus erythematosus.Lupus nephritis in children - 10 years' experience.Premature vascular damage in systemic lupus erythematosus.Thrombosis in systemic lupus erythematosus: risk and protection.Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.

P2860

Q24613829-FD4067EB-0A42-4B28-8BC0-4450A2BDFF22 Q26741266-71880804-AA32-495F-95E9-AC41521DAEC3 Q26782822-FFA3EB47-0097-4510-8290-E08570618CED Q27302392-203FAF01-9A6A-4D7E-AC88-DA68DDFF2AC6 Q28265144-4154310D-7660-4944-9712-B4E91492DC8E Q28546985-71481889-484B-4488-B969-A19D96F74599 Q30778909-B166BC6B-C81B-4210-BD12-BA9736562D44 Q31129756-097FFF46-8D56-483A-903C-CEA5C510FA47 Q33422958-E5838A3D-EF20-4B4B-86C5-70F99B35B444 Q33448450-A077BA34-969E-435B-BBEF-2D01ABF3E36B Q33455990-E39A380E-31ED-47C9-9158-B47A2D9E1E97 Q33497970-D2623D62-45FE-41FC-B48F-847685489DF3 Q33555419-62963C58-D36C-498A-904B-0C8F292A4EAA Q33945242-89C3877E-90FB-48A0-8C51-1E8938B60D29 Q34044918-95C59B87-5CA0-42F6-9044-593F061F6018 Q34081242-ADF84AF3-2C17-43AA-9468-BCAB3D8948D2 Q34161393-6F2467B1-C2CE-4864-8E9D-17659BF24C3B Q34162739-FFB330D1-8C9F-4226-9D03-AFC84D72510C Q34338929-0A476B08-DAE2-44AA-9015-359B6377D49C Q34498515-B75F11D3-6D07-4FFF-A1FB-F897F5EAA585 Q35756117-009FEE66-A3A4-4326-B6BD-98E5CEF4B6E0 Q36152835-24E56AF2-906B-4A8E-A3CB-6FC34EF11C5B Q36220831-DD2D0A48-EB69-422E-AB9F-1DF15C47B56D Q36234766-113482DB-D9F8-4ED4-AC22-EE62D6972212 Q36240425-D90B56F8-94AD-4CDB-8FB4-B0DE91B411E1 Q36307429-0D85077C-9F42-42E6-8015-6088EA5810B9 Q36551073-6D1AEE93-2A3D-416E-8522-6424E3EEAB95 Q36573884-CCC81B46-C1A2-4363-86ED-DF7A12C76719 Q36606667-73DAB646-5DB2-4762-B736-0135E76EAA9E Q36746012-F98B5541-5924-4AE8-BC45-549AF9B428D8 Q36906782-F655926C-1E0D-449F-B98D-E3C619AB38D9 Q37033345-80C97AD4-4170-4CCB-AB9C-7E4CB3B5A71A Q37137299-DB96BFAD-D3BB-4F70-B064-B43B93C3DCE4 Q37330468-053E5699-574C-4213-ABBC-C371CA5653CE Q37350893-5C0B63DD-A8C4-4E6E-AD48-81D324F508FB Q37399315-5C115424-928A-42F2-9E7F-DBD4A1136C95 Q37573524-D7E34D5C-6B28-4347-BCDF-93ACBB4CD94D Q37642828-9D657DEE-4603-4506-968E-E821691572AB Q37854742-5FC5500D-3AAC-420D-B608-5C4C149E1F72 Q37883018-002851C6-8A40-49A8-AEBE-2935354131BF

P2860

Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)

http://www.wikidata.org/entity/Q31107094

description

2007 nî lūn-bûn

@nan

2007 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մարտին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Effect of hydroxychloroquine o ...... ltiethnic US cohort (LUMINA L)

@ast

Effect of hydroxychloroquine o ...... ltiethnic US cohort (LUMINA L)

@en

type

label

Effect of hydroxychloroquine o ...... ltiethnic US cohort (LUMINA L)

@ast

Effect of hydroxychloroquine o ...... ltiethnic US cohort (LUMINA L)

@en

prefLabel

Effect of hydroxychloroquine o ...... ltiethnic US cohort (LUMINA L)

@ast

Effect of hydroxychloroquine o ...... ltiethnic US cohort (LUMINA L)

@en

P1433

Q31107094-FFF320DE-8C21-4A9C-88DF-183BDEE44B59

P1476

Q31107094-744E074C-0E98-419B-ABCC-270727F9BF30

P2093

Q31107094-30BA9DAB-CA4B-4415-B4F5-0A30AF86CFEF

Q31107094-585FD073-89CA-401B-BCE4-1809C37CBD72

Q31107094-7394444F-95B8-4D1B-8DE0-735BC7D5BF25

Q31107094-94F97867-7106-46E5-B254-8189C333356A

Q31107094-A22B12D4-001D-4988-8DF6-FCA6FFC2C1F7

Q31107094-BC5FD2AC-A6BA-40CF-9D35-C7EC0555C141

Q31107094-D1B44DCF-D24D-4F67-AEBC-2819DB38D750

P2860

Q31107094-1C7AF0D0-25B8-40AD-A188-B0DC27184647

Q31107094-28A49D3B-B44D-48AC-B5E6-B84C2CC86C29

Q31107094-356B063B-0F68-4468-AAA6-AB565CAB33FD

Q31107094-40593D7D-01FA-4325-B1E2-3A3831192EBE

Q31107094-45A538D9-8CFA-4A48-96C8-E97506119619

Q31107094-45F8380A-823A-480C-BB86-CC6E521C0CD7

Q31107094-46A41716-E66D-43C8-9454-302C40E97085

Q31107094-4D8B2010-F957-4EE4-978C-E5E64A4DD296

Q31107094-59C38CBD-B4E1-4052-8FC4-72E8DEC09ADC

Q31107094-6E1B92A9-041A-4D9D-B84C-EDFBCF139C64

P304

Q31107094-ADFC442F-B323-4A13-8B22-A2E9AE8B782C

P31

Q31107094-F485A0A4-3433-4860-A64A-3448D95A3BF5

P356

Q31107094-4F76124B-986B-498F-86B2-F8023C210471

P407

Q31107094-9C8CA0E5-0E81-45C4-A245-30CE43F227B8

P433

Q31107094-56956FA0-352F-4410-8DAA-779976FC5C33

P478

Q31107094-552E2C1E-D1AD-472C-BB11-0C71FCDF12E1

P50

Q31107094-4D0D0CA2-7282-4050-A47B-8958CD6E11C6

Q31107094-8DC8537C-5D76-4743-B563-0A5F429E871C

P577

Q31107094-F6F4FCA8-3CDA-42CA-BC10-53B6601163F5

P5875

Q31107094-8702E594-BB98-4C0E-9185-3294C5EC7B6E

P698

Q31107094-36751956-B457-4DB3-A5A5-28D9921BF992

P921

Q31107094-B8A3A47A-588F-40D2-BF21-CC312AA6504E

Q31107094-E084DE71-0F41-45FF-A982-D34CA7BD5EEA

P932

Q31107094-D38AA4B3-E2DA-4A31-B8D9-A7D2F19BE797

P356

ARD.2006.068676

P1433

Annals of the Rheumatic Diseases

P1476

Effect of hydroxychloroquine o ...... ltiethnic US cohort (LUMINA L)

@en

P2093

Barri J Fessler

http://www.w3.org/2001/XMLSchema#string

Gerald McGwin

http://www.w3.org/2001/XMLSchema#string

Graciela S Alarcón

http://www.w3.org/2001/XMLSchema#string

Holly M Bastian

http://www.w3.org/2001/XMLSchema#string

Jaime Calvo-Alén

http://www.w3.org/2001/XMLSchema#string

LUMINA Study Group

http://www.w3.org/2001/XMLSchema#string

Luis M Vilá

http://www.w3.org/2001/XMLSchema#string

P2860

Discontinuation of antimalarial drugs in systemic lupus erythematosus

The 1982 revised criteria for the classification of systemic lupus erythematosus

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Antimalarials--the 'real' advance in lupus.

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis.

Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual.

Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.

A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group.

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus.

P304

1168-1172

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.2006.068676

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

John D Reveille

P577

2007-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51374624

http://www.w3.org/2001/XMLSchema#string

P698

17389655

http://www.w3.org/2001/XMLSchema#string

P921

hydroxychloroquine

P932

1955128

http://www.w3.org/2001/XMLSchema#string